Scientists investigated whether gilteritinib, a selective FLT3 inhibitor, could enhance graft-versus-leukemia effects against FLT3 internal tandem duplication mutant transfected Ba/F3 leukemia in mice.
[Bone Marrow Transplantation]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172361
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/